TORONTO, ONTARIO -- (MARKET WIRE) -- May 30, 2007 -- PharmEng International Inc. (TSX VENTURE: PII), a full-service consulting and contract manufacturing company, today reported its results for the period ended March 31, 2007. The Company, while investing in the pharmaceutical manufacturing operations, continues its consulting revenue growth in Canada, the USA and internationally.
